TAI-SHUAN LAIWEN-CHIH CHIANGYUNG-MING CHEN2020-12-242020-12-2420160929-6646https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955168191&doi=10.1016%2fj.jfma.2015.12.010&partnerID=40&md5=d0ebe021abd329f1515fdc164d88de78https://scholars.lib.ntu.edu.tw/handle/123456789/532669[SDGs]SDG3creatinine; pentoxifylline; pentoxifylline; phosphodiesterase inhibitor; creatinine blood level; diabetic nephropathy; drug effect; glomerulus filtration rate; human; microalbuminuria; nonhuman; proteinuria; renal protection; Short Survey; complication; diabetic nephropathy; Kidney Failure, Chronic; proteinuria; retrospective study; Taiwan; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Pentoxifylline; Phosphodiesterase Inhibitors; Proteinuria; Retrospective Studies; Taiwanshort survey10.1016/j.jfma.2015.12.010268178332-s2.0-84955168191